Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Sleep Quality and Cognition in Young Adults

14. april 2021 opdateret af: mbudak, Istanbul Medipol University Hospital

The Relationship Between Sleep Quality and Cognition in Young Adults

Sleep quality is impaired in young adults due to current conditions. Recent studies emphasize that this situation may also affect the cognitive status of individuals. The aim of this study was to investigate the relationship between sleep quality and cognitive status in young adults. A total of 122 young adults (61 female, 61 male) aged between 18 to 25 and studied at Istanbul Medipol University, Faculty of Health Sciences, were included in the study. Individuals were evaluated with "Pittsburgh Sleep Quality Index (PSQI)" for sleep quality; with "Montreal Cognitive Status Scale (MoCA)" for cognitive status, with "STROOP Test" for selective attention; with "Verbal Fluency Test" for sustained attention; with "WMS-R digit Span Test" for auditory attention

Studieoversigt

Status

Afsluttet

Betingelser

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

122

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Istanbul, Kalkun, 34815
        • Istanbul Medipol University

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 25 år (Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Healthy adults aged between 18 to 25

Beskrivelse

Inclusion Criteria:

  • Signing the Informed Voluntary Consent Form
  • Being in the age range of 18-25

Exclusion Criteria:

  • having a sleep disorder

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Study Group
A group of young adults aged between 18 to 25
Sleep quality and cognition will be assessed in young adults

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Pittsburgh Sleep Quality Index
Tidsramme: 8 March - 26 April 2019
Pittsburgh Sleep Quality Index evaluates sleep quality and impairment in the last one month. 19 of the 24 PSQIquestions included were self-report questions. The scale has 18 questions and 7 components: Subjective Sleep Quality "," Sleep Latency "," Sleep Duration ", "Sleep Efficiency", "Sleep Disturbance", "Sleep Medication" and Daytime Dysfunction". The total score ranges from 0-21. A total score greater than 5 indicates poor sleep quality.
8 March - 26 April 2019
Montreal Cognitive Assessment Test
Tidsramme: 8 March - 26 April 2019
Montreal Cognitive Assessment Test (MoCA) examines cognitive abilities such as visual / executive function, naming, episodic memory, attention, language, abstract thinking, and orientation. The original cut-off score of the MoCA test is 26. The cut-off score of 21 was adopted in Turkey. MoCA takes about 10 minutes to apply, but shortened versions have been created to shorten the administration time
8 March - 26 April 2019

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
STROOP Test
Tidsramme: 8 March - 26 April 2019
The Stroop Test reflects selective attention, reading and color rendering processes. It is a critical experimental task, often used in the study of automatic and parallel processing models with the speed of information processing. Because of these features, the test is used not only in the evaluation of the cognitive processes of healthy individuals, but also in the evaluation of many psychiatric and neurological disorders
8 March - 26 April 2019
Verbal Fluency Test
Tidsramme: 8 March - 26 April 2019
Verbal Fluency Test evaluates the tasks performed with frontal and temporal lobe activation. The purpose of this test is to evaluate the mental recall of words starting with the given letter or in the desired category within the prescribed time.
8 March - 26 April 2019
WMS-R digit Span Test
Tidsramme: 8 March - 26 April 2019
Digit Span Test is the eighth subtest in the Wechsler Memory Scale Developed Form, and evaluates the simple and complex attention of individuals. This sub-test consists of two sub-sections, and a series of increasingly long numbers are read to the person. Both subtests are related to auditory attention and short-term memory. Two separate trials are made for each length sequence.
8 March - 26 April 2019

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

8. marts 2019

Primær færdiggørelse (Faktiske)

26. april 2019

Studieafslutning (Faktiske)

21. januar 2020

Datoer for studieregistrering

Først indsendt

10. april 2021

Først indsendt, der opfyldte QC-kriterier

10. april 2021

Først opslået (Faktiske)

15. april 2021

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

19. april 2021

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

14. april 2021

Sidst verificeret

1. april 2021

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • SleepCog2021

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner